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Abstract
Background: Linear scleroderma "en coup de sabre" (LSCS) usually affects one side of the face
and head in the frontoparietal area with band-like indurated skin lesions. The disease may be
associated with facial hemiatrophy. Various ophthalmological and neurological abnormalities have
been observed in patients with LSCS. We describe an unusual case of LSC.
Case presentation: A 23 year old woman presented bilateral LSCS and facial atrophy. The
patient had epileptic seizures as well as oculomotor and facial nerve palsy on the left side which
also had pronounced skin involvement. Clinical features of different stages of the disease are
presented.
Conclusions: The findings of the presented patient with bilateral LSCS and facial atrophy provide
further evidence for a neurological etiology of the disease and may also indicate that classic
progressive facial hemiatrophy (Parry-Romberg syndrome) and LSCS actually represent different
spectra of the same disease.
Background
Linear scleroderma "en coup de sabre" (LSCS) is a sub-
type of localized scleroderma (Tab. 1). LSCS, usually de-
veloping in the first or second decade of life, presents as
band-like sclerotic lesions with more or less marked skin
discoloration of the frontoparietal area. Characteristical-
ly, LSCS manifests unilaterally and does not extend be-
low the eyebrow. The active stage usually lasts two to five
years. Involutionary atrophy of skin, muscle, and even
bone may occur. Neurological and ophthalmological ab-
normalities are not infrequent in LSCS [1–3]. We present
an uncommon case of bilateral LSCS with facial atrophy
and several neurological complications.
Case presentation
A 23-year-old woman presented with band-like sclerotic
lesions and cicatricial alopecia on the left frontoparietal
area (upper trigeminal dermatome). In this area, there
was remarkable atrophy of skin and underlying tissues.
She had complete ptosis of the left eye. Veins was clearly
seen through the atrophic skin in the left temporal re-
gion. There was also a remarkable subcutaneous cleft
above the right eyebrow and a nearly complete loss of the
left eyebrow (Figs 1,2,3,4,5). The tongue or gums were
not involved. The patient refused a skin biopsy from the
frontal area. Onset of the disease was reported to have
been at age 7, with a small scleroderma-like lesion on the
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ceded by trauma. Over the succeeding years, the sclerotic
changes and atrophy gradually spread over the almost
complete left frontoparietal area. The lesions did not re-
spond to various treatment protocols including penicillin
G and topical hydrocortisone. At the age of 16, a transcra-
nial orbitotomy and frontal advancement was performed
on the left side of the face. Because of her history of two
grand-mal seizures, which had occurred during the last
two years, she had anticonvulsant therapy with car-
bamazepine 600 mg daily. There was no family history
for scleroderma or hemiatrophies.
Neurological examination showed peripheral facial
nerve palsy on the left side. Complete oculomotor nerve
palsy of the left eye was confirmed by ophthalmological
investigation. Laboratory investigations, including anti-
nuclear antibodies and serology for B. burgdorferi, elec-
trocardiography, abdominal sonography, and chest X-
ray, did not yield abnormalities. Cranial magnetic reso-
nance imaging (sagittal T1, axial T2, FLAIR before and
after contrast medium injection) showed no pathological
intracranial findings. Since the patient was intended for
bony reconstruction surgery, 3-dimensional reconstruc-
tion images were performed using a spiral computed to-
mography scanner (Somatom Plus S, Siemens, Iselin,
USA). Contiguous 2 mm axial slices of the facial skull
were taken at 2 mm intervals. Oblique coronal, oblique
sagittal, and 3-dimensional images were subsequently
Figure 1
The 7-year-old girl without recognizable features of LSCS.
Table 1: Variants of localized scleroderma recently classified by 
Tuffanelli [2]
I. Localized scleroderma
a) Morphea [plaque-type; guttate; profound; nodular; bullous; 
Atrophoderma of Pasini and Pierini]
b) Linear scleroderma ["en coup de sabre"; with facial atrophy 
(Parry-Romberg syndrome); acral; with arthritis, myositis, and 
growth defects of bone; melorheostotic]
c) Generalized morphea [pansclerotic; edematous; with lichen 
sclerosus]
II. Localized scleroderma as a component of an overlap syndrome
a) Mixed connective tissue disease
b) Undifferentiated connective tissue disease
c) Sclerodermatomyositis
III. Localized scleroderma as a component of eosinophilic fasciitis (Shul-
man's syndrome)
Figure 2
The 11-year-old girl with discrete facial palsy and mild facial
atrophy of the left frontoparietal area.
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on the left side were demostrated, in particular involve-
ment of the frontal bone, orbital floor, and maxillary si-
nus (Fig. 6).
Discussion
In the present case, band-like scleroderma and facial at-
rophy of the frontoparietal area was observed. The skin
involvement did not extend below the forehead. These
features were consistent with a diagnosis of LSCS with
facial atrophy [1–3]. In classic progressive facial hemiat-
rophy or Parry-Romberg syndrome (PRS), cutaneous in-
flammation, induration, and adhesion are absent or
minimal, and atrophy usually involves the one entire side
of the face [4–6]. It has been suggested that the term PRS
should only be used for progressive hemifacial atrophy
occurring without features of scleroderma [2]. However,
a clear differentiation between PRS and involutionary
LSCS is often not possible, and it is rather an arbitrary
approach to differentiate the two diseases because of
their extend on the face and more or less sclerosis, de-
spite of all their common features observed. Although
preceding sclerosis was never noticed in many cases of
PRS, Jablonska and Blaszczyk [1] observed several pa-
tients with typical LSCS in children converting within
several years into facial hemiatrophy. Thus the time of
investigation is of significance when diagnosing either
LSCS or PRS. There are no reliable histological criteria to
differentiate PRS from involutionary scleroderma. Re-
cently, Blaszczyk et al. [7] reported three cases of prima-
ry atrophic profound linear scleroderma with
involvement of the subcutis and deeper tissues. In ac-
cordance with a previous report of Malandrini et al. [8],
deep skin biopsies showed inflammatory infiltrates in
the endomysium and perimysium. Interestingly, atrophy
was not preceded by clinical evidence of inflammation,
Figure 3
The 16-year-old girl with facial palsy, complete ptosis, and
marked atrophy of subcutaneous and bony structures on the
left upper side of the face before surgical intervention. Note
the slight cleft above the right eyebrow and rarefication of
the left eyebrow.
Figure 4
The 23-year-old woman with facial palsy, complete ptosis,
and improvement of facial asymmetry (as compared to Figure
3). Note the deep subcutaneous cleft above the right eye-
brow and almost complete loss of the left eyebrow.
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concluded that PRS could be regarded as a variety of
deep linear scleroderma [7,9].
Common theories on the etiology of LSCS are: firstly,
that the localized forms of scleroderma are related in the
same manner as discoid and systemic lupus erythemato-
sus and thus belonging in the collagen-vascular group of
diseases with autoimmune phenomena or secondly, that
localized scleroderma is a developmental disease, occa-
sionally associated with other (predetermined) defects
[2]. Other theories implicate that viral or bacterial infec-
tions (e.g. B. burgdorferi) and genetic factors may play a
role in the etiology of LSCS [1]. However, a multifactorial
pathogenesis of hemiatrophies is most likely. Ophthal-
mological (e.g. iridocyclitis, enophthalmus, exophthal-
mus) and/or neurological (e.g. intracerebral
calcification, hemiplegic headaches, epileptic seizures)
manifestations have frequently been observed in pa-
tients with LSCS and PRS [2–4,10,11]. Besides, non-neu-
rogenic myopathy associated with LSCS has previously
been reported [11,12]. However, cranial nerve palsy coex-
isting with LSCS or PRS is a rarity. The involved areas in
LSCS do usually not cross the midline and may resemble
innervated fields in a cranial nerve distribution, in par-
ticular the upper trigeminal dermatome, raising the pos-
sibility of a neurogenic origin. It has therefore been
suggested that LSCS and PRS result from hyper- or hy-
poactivity of sympathetic nervous system or abnormality
of the trigeminal nerve. Pathological evidence of intrac-
erebral inflammation in a patient with LSCS has recently
been observed by Stone et al. [13]. Accordingly, we sug-
gest that computed tomography and magnetic resonance
imaging are useful diagnostic tools for the investigation
of patients with LSCS, in particular for detecting clinical-
ly inapparent intracranial changes [13,14]. In the present
Figure 5
The 23-year-old woman with LSCS and cicatricial alopecia on
the left parietal region.
Figure 6
3-dimensional reconstruction image of the 16-year-old girl
before urgical intervention. Remarkable hypoplasia of the
frontal bone on the left side (arrows).
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lateral lesions of LSCS have been considered to be ex-
tremely rare [15]. Lateralization of LSCS possibly
indicates a neuropathological etiology of the disease. No-
tably, there were no preceding clinical features of sclero-
derma in the atrophic area affecting the right forehead of
our patient indicating that the atrophic cleft on the right
forehead was caused by profound linear scleroderma [7].
The management of localized scleroderma is still unsat-
isfactory. Various therapeutic modalities (e.g. topical
and pharmacological agents, immunosuppresion, physi-
otherapy, and phototherapy) have been suggested [16].
In an uncontrolled study, we have recently observed that
childhood scleroderma can successfully be treated with
topical calcipotriol and low-dose UVA1 phototherapy
[17]. However, management of facial atrophy is a chal-
lenge. As shown in the presented case, palliative recon-
struction surgery is potentially beneficial for patients
with disfiguring facial atrophy, and the employment of 3-
dimensional reconstuction imaging may be helpful in pr-
eoperative scheduling of bony reconstruction surgery
[18].
List of abbreviations
LSCS : linear scleroderma "en coup de sabre";
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